Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35) - Wikidata - awgldk - TriplyDB

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

http://www.wikidata.org/entity/Q36367223

about

Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes T cell response to Hu-D peptides in patients with anti-Hu syndrome Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans Thymic selection generates a large T cell pool recognizing a self-peptide in humans Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface Evidence of the extrathymic development of tyrosinase-related protein-2-recognizing CD8+ T cells with low avidity Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100.Vitiligo puzzle: the pieces fall in place.MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans.Human tumor antigens for cancer vaccine development.T-cell recognition of melanoma-associated antigens.Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide.Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma Cross-reactivity in T-cell antigen recognition.Use of tumour-responsive T cells as cancer treatment.Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models Peptide vaccines for cancer.Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity.Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillanc The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope.Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma.Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes.Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer.Tumor immunity and autoimmunity induced by immunization with homologous DNA The use of endogenous T cells for adoptive transfer.TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8(+) T-cell responses.High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.Poly-glutamic dendrimer-based conjugates for cancer vaccination - a computational design for targeted delivery of antigens.Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients

P2860

Q22009435-5F4A43C6-AA3A-4084-BEAE-F4957C6AFF3D Q24654675-65946A5D-4DC6-49FC-9FBA-7990D92478E3 Q24673373-19AD7573-76C6-4944-A62E-B6C6181BECF6 Q24675080-6A934FBE-7CBD-49B9-92A5-3EC6375D0E62 Q24802424-F45BC046-A11C-472E-94B6-8D251A8688DB Q27635182-DF9D93CA-8E54-4408-89AA-5832C5CCB779 Q28360452-DC6D6809-E69A-4DDE-85EC-CA3FABD87D8E Q30304153-BDC3A54D-245B-4875-9824-37B70B303596 Q33344607-D45A9398-3224-4C3C-8AF8-2D5F1048F709 Q33646658-A0E0E55D-4898-4524-A810-690BE3CB70F3 Q33776127-5C4D8386-5A13-4C9E-B041-CD0F0D5A7074 Q33827458-A6AF5B6E-A84E-4BAA-8766-F63BC190C626 Q33909760-4231A48C-D72F-4308-8A83-9E9962B213B0 Q34111789-6EF80969-B1DC-4FF3-82E8-5558B899A860 Q34249351-FCA39D98-2C08-44AB-846F-4939025DD8D3 Q34285656-0E1E8F6D-0AEB-4625-8A02-AC8E51028950 Q34360520-10D4BF2F-147A-4B4C-AAE8-F8144BD3CC28 Q34568992-36F1783D-666F-4FCF-A715-7B94AC2099B7 Q34594769-5B830485-7BF7-4549-9B59-8A9F614EB6C4 Q34606735-298C2D6A-ED31-43E2-BB71-71C3972C2D88 Q34975376-5698E087-7C38-44BD-ADC8-A8F398BB8316 Q35146595-0D2CC147-7C4F-46DB-8FF9-71C1368DE72B Q35165666-FE6E27CD-A266-46A9-BD1C-45A20D520AEF Q35880416-0A489443-DF88-4A3C-B1C0-369D6D96BE4F Q36150417-76F14FD2-3424-4469-BF71-E7BB9F91F872 Q36375260-7E296AA0-98BC-4DE0-923A-B521CDF001BA Q36375353-098B2956-D451-47A6-8ED2-788DEF31337B Q36376523-74C93273-7B03-40F1-BAE8-B42EDF52B5D8 Q36835348-311FEEF4-56C1-4315-8B33-70C9C4091FB4 Q36924579-CD2CA299-43D4-47EE-A3AD-4A3A6A567DB3 Q37001399-0B6C307F-1013-4F27-9BB3-EC01CBB981C5 Q37387673-2DCBFBBD-515C-4CE0-A3BA-C29FEA2E0FC6 Q38170503-A4AA8AC8-0903-4D54-91BF-5F24A811D39A Q38671405-09F82667-993E-45A6-8D5E-F4681ADA88F7 Q40953830-CCE6AFB0-85CF-4C00-B2D7-F265C72D8BDF Q42947076-55436E52-0B93-49B3-9976-EA541BC0CBE1 Q50506338-76573E3C-632B-471E-BAB9-1F93AF497934 Q52013647-8691228B-4580-47BB-97D4-8A0624AAC17F Q57209299-DFAE9D85-64B4-4456-88C4-92A72FE3846D Q57810732-193EE102-1587-4524-B525-E2E39CE8D981

P2860

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

http://www.wikidata.org/entity/Q36367223

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh

1996年學術文章

@zh-hant

name

Identification of epitope mimi ...... -derived peptide MART-1(27-35)

@ast

Identification of epitope mimi ...... -derived peptide MART-1(27-35)

@en

type

label

Identification of epitope mimi ...... -derived peptide MART-1(27-35)

@ast

Identification of epitope mimi ...... -derived peptide MART-1(27-35)

@en

prefLabel

Identification of epitope mimi ...... -derived peptide MART-1(27-35)

@ast

Identification of epitope mimi ...... -derived peptide MART-1(27-35)

@en

P1433

Q36367223-ED37B3C6-B084-447F-94A5-95F32CA3AE54

P1476

Q36367223-F45B3424-F62E-45CE-AEB5-C5D2BD6ED10C

P2093

Q36367223-051AE7CE-7251-406D-8A19-C8ADCCC81FB1

Q36367223-134BD79C-E647-45EA-BE7B-88966FA2AD75

Q36367223-3877D13D-6861-4A82-B3C7-99354563E081

Q36367223-4D5E4725-69FD-416E-9C1E-B103DBCB422E

Q36367223-76F36467-9843-4FB5-98C2-9C42E858D71B

Q36367223-89FFE008-F1C8-412D-8B32-D517B8F33FE9

Q36367223-BD022FB5-5748-4C49-A283-2E1110783D5B

Q36367223-C036EF87-BA17-443A-BAD8-5E2B93D1C871

Q36367223-ED5F709E-0D7E-49F2-A2D8-5D3977EB04E2

P2860

Q36367223-085CCE0B-B94D-44F1-B92B-6C69C9426181

Q36367223-099464FB-332C-41B7-95D5-72F33A2CD10D

Q36367223-0A27FA5C-4DD8-4394-8BF5-42EBE617C18D

Q36367223-1954B9FE-4A18-4346-9BAF-BB8181E4DAA1

Q36367223-1D134C5F-8CE9-4945-B5ED-7F89E08BF851

Q36367223-2161CEB2-3C43-4056-8C36-C287F9EE415A

Q36367223-22932348-4E39-4549-B98D-583266512CE5

Q36367223-24E632A2-89CB-4E22-AFA3-4DDD3B2EA0DB

Q36367223-251A95C3-921D-4505-BC9C-97D27EC44242

Q36367223-3C85B71C-35F0-4C50-9561-C587A0E26F25

P304

Q36367223-538B05A5-97BA-4B24-A135-706C309E2A94

P31

Q36367223-19DB4F2D-694B-481D-860B-DDF1B77C93D5

P356

Q36367223-AC0730B2-0295-4DD3-BC81-58B6FDA5B358

P407

Q36367223-3A8D7833-C17D-4955-8225-1D217208AD18

P433

Q36367223-775C1663-D47C-4019-A918-84F76CD63E7A

P478

Q36367223-F18858A7-0CFC-47EF-ABAA-FEF5DCE41884

P577

Q36367223-EE623A12-A6B0-4F35-B23F-2687F7D70BD8

P5875

Q36367223-8384CBB7-AF35-4E5B-82A9-AADE628111C9

P698

Q36367223-8605A99A-E713-4EDA-8730-259FC3CC2C43

P932

Q36367223-7F47A486-3877-45F9-9767-699083188F00

P356

P1433

Journal of Experimental Medicine

P1476

Identification of epitope mimi ...... -derived peptide MART-1(27-35)

@en

P2093

Appella E

http://www.w3.org/2001/XMLSchema#string

Castelli C

http://www.w3.org/2001/XMLSchema#string

Clay TM

http://www.w3.org/2001/XMLSchema#string

Loftus DJ

http://www.w3.org/2001/XMLSchema#string

Marincola FM

http://www.w3.org/2001/XMLSchema#string

Nishimura MI

http://www.w3.org/2001/XMLSchema#string

Parmiani G

http://www.w3.org/2001/XMLSchema#string

Rivoltini L

http://www.w3.org/2001/XMLSchema#string

Squarcina P

http://www.w3.org/2001/XMLSchema#string

P2860

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry

Improved tools for biological sequence comparison.

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

P304

647-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.184.2.647

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P577

1996-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

246573403

http://www.w3.org/2001/XMLSchema#string

P698

8760818

http://www.w3.org/2001/XMLSchema#string

P932

2192745

http://www.w3.org/2001/XMLSchema#string